Obesity affects 41% of Americans, and with the recent rise in popularity of GLP-1 drugs, more people are looking to use them to achieve their weight-loss goals. However, these drugs are expensive to both employees and the plan overall. This week, Jackie Warren, Director of Data and Reporting for Engagement Health Group, joins this week's episode to discuss how to GLP-1s should be utilized to both achieve weight-loss goals and keep plan costs low.
How to Identify High-Value Family-Forming Benefits
Navigating the GLP-1 Wave: Strategies for 2024
Collaboration to Overcome Challenges
Bringing Savings to Plan Members with Reference Based Pricing
Using Data to Understand Your Population's Needs
Total Health with Advanced Primary Care
Avoiding Adverse Side Effects
Not Surgery - Recovery Using the Body's Own Cells
An International Pharmacy
MasterClass for Juniors
The Importance of Family-Forming Benefits
A Captive as a Shock Absorber
It All Starts With a Budget
Gag Clause Attestation
City-Builders of Direct Primary Care
A Partnership Made in Total Worker Health Heaven
Surgeons of Excellence
Providing the Missing Human Element
Introducing FoodMed Certified
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money